Status | Study |
Recruiting |
Study Name: Study of Pembrolizumab (MK-3475) vs Standard Therapy in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Carcinoma (MK-3475-177/KEYNOTE-177) Condition: Colorectal Carcinoma Date: 2015-09-28 Interventions: Drug: mFOLFOX6 Regimen consist |
Active, not recruiting |
Study Name: Study of Pembrolizumab (MK-3475) as Monotherapy in Participants With Previously-Treated Locally Advanced Unresectable or Metastatic Colorectal Cancer (MK-3475-164/KEYNOTE-164) Condition: Colorectal Carcinoma Date: 2015-05-29 Interventions: Biological: Pembrolizumab IV infusion Other Names: |
Recruiting |
Study Name: Deciphering Antitumour Response and Resistance With INtratumour Heterogeneity Condition: Non-small Cell Lung Cancer Date: 2014-12-05 Interventions: Drug: MPDL3280A Intravenous (I |
Not yet recruiting |
Study Name: Diagnostics for the Treatment of Progressive Mucosal Lesions of the Oral Cavity: a Prospective Study Condition: Chromosomal Instability Low Grade Dysplasia Oral Cavity Lo Date: 2014-09-09 Interventions: Procedure: surgery excision or |
Recruiting |
Study Name: A Phase 1/2 Study Exploring the Safety, Tolerability, and Efficacy of Pembrolizumab (MK-3475) in Combination With Epacadostat (INCB024360) in Subjects With Selected Cancers (INCB 24360-202 / MK-3475-037 / KEYNOTE-037/ ECHO-202) Condition: Malignant Solid Tumor Lymphoma, Large B-Cell, Diffuse Carc Date: 2014-06-26 Interventions: Drug: MK-3475 IV infusion |
Recruiting |
Study Name: Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Metastatic Colorectal Adenocarcinoma Condition: Metastatic Colorectal Adenocarcinoma Date: 2012-07-09 Interventions: Drug: Gemcitabine intravenous |
Completed |
Study Name: Bioactive Plant Foods: Effects on Functional Bioavailability and Genomic Stability Condition: Metabolic Syndrome Date: 2009-08-20 Interventions: Dietary Supplement: plant based nutrition bar Nutrition bars made from Angelica keiskei (5g), glycine ma |
Completed |
Study Name: Molecular Biology of Anal Cancer in HIV-Positive Patients Condition: Carcinoma HIV Infections Date: 2009-08-03 |
Completed |
Study Name: Efficacy and Safety of Olaparib in Pretreated Patients With Measurable Colorectal Cancer, Stratified by Microsatellite Instability (MSI) Status Condition: Colorectal Cancer Date: 2009-05-28 Interventions: Drug: olaparib 400 mg po bid continuously |
Completed |
Study Name: Genetic Study of Young Patients With Colorectal Cancer Condition: Colorectal Cancer Date: 2002-09-06 Interventions: Genetic: microsatellite instability analysis |